Therapeutic Intervention Supporting Development From NICU to 6 Months for Infants Post Hypoxic-Ischemic Encephalopathy
Cerebral Palsy, Hypoxic-Ischemic Encephalopathy
About this trial
This is an interventional other trial for Cerebral Palsy focused on measuring infant
Eligibility Criteria
Inclusion Criteria:
- Infants with moderate or severe hypoxic-ischemic encephalopathy (HIE) based on the modified Sarnat Exam on admission and has started to receive therapeutic hypothermia for 72 hours.
- Cared for in the Newborn and Infant Critical Care Unit (NICCU) at Children's Hospital Los Angeles (CHLA).
- Family lives within 60 miles of CHLA.
- One parent/legal guardian has provided signed and dated informed consent form agreeing to the child's participation and the parent's own participation.
Exclusion Criteria:
- Infant born preterm.
- Infant with congenital anomalies, chromosomal or microarray abnormalities.
- Infant with microcephaly.
- Infants who have been redirected for comfort care.
- Infants who are medically unstable.
Sites / Locations
- Children's Hospital Los AngelesRecruiting
- University of Southern California
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Usual Care
Sensorimotor Intervention
Infants randomly assigned to this arm will not receive any study intervention but will continue with any intervention in the community recommended by their health care team.
Infants randomly assigned to this arm will participate in the sensorimotor intervention starting in the hospital and lasting for 6 months. This intervention includes 10 visits with a physical or occupational therapist and parent working together to advance an intervention program and 6 months of parent daily intervention. In addition, this arm will continue with any intervention in the community recommended by their health care team.